From a diagnostic perspective, the study reported a urinary HMGB1 cut-off value of 63.3 pg/mL to differentiate bladder cancer from urinary tract infections, with a specificity of 77% and sensitivity of 59%, and an AUC of 0.813 against healthy controls—supporting its clinical potential. The gene discussed is HMGB1; the disease is urinary tract infection.